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Abstract
In order for a virus to persist, there must be a balance between viral replication and immune
clearance. It is commonly believed that adaptive immunity drives clearance of viral infec-
tions and, thus, dysfunction or viral evasion of adaptive immunity is required for a virus to
persist. Type I interferons (IFNs) play pleiotropic roles in the antiviral response, including
through innate control of viral replication. Murine norovirus (MNoV) replicates in dendritic
cells (DCs) and type I IFN signaling in DCs is important for early control of MNoV replication.
We show here that the non-persistent MNoV strain CW3 persists systemically when CD11c
positive DCs are unable to respond to type I IFN. Persistence in this setting is associated
with increased early viral titers, maintenance of DC numbers, increased expression of DC
activation markers and an increase in CD8 T cell and antibody responses. Furthermore,
CD8 T cell function is maintained during the persistent phase of infection and adaptive
immune cells from persistently infected mice are functional when transferred to Rag1-/-
recipients. Finally, increased early replication and persistence are also observed in mixed
bone marrow chimeras where only half of the CD11c positive DCs are unable to respond to
type I IFN. These findings demonstrate that increased early viral replication due to a cell-
intrinsic innate immune deficiency is sufficient for persistence and a functional adaptive
immune response is not sufficient for viral clearance.
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Author Summary
In vertebrates, innate immunity provides early control of viral infection and initiates adap-
tive immunity. It is generally thought that a virus must either avoid or evade an adaptive
immune response to persist within a vertebrate host. The role of innate immunity in pre-
venting viral persistence, apart from its role in initiating an adaptive response, is not
completely understood. Type I interferon (IFN) is a cytokine with pleiotropic roles in
the antiviral response, including innate control of viral replication. Murine norovirus
(MNoV) replicates in cells of the innate immune system, including dendritic cells (DCs),
and IFN signaling in DCs is important for early control of MNoV replication. We found
here that MNoV persists when DCs are unable to respond to type I IFN. MNoV persis-
tence is correlated with increased adaptive immune responses, likely reflective of increased
early viral replication. MNoV also persists in chimeric mice with a 50% mix of wild-
type and type I IFN receptor deficient DCs, consistent with a cell-intrinsic role for IFN
responses in preventing MNoV persistence. These findings demonstrate that an innate
immune deficiency can result in viral persistence apart from its role in generating an adap-
tive immune response.
Introduction
The immune response to many commonly encountered viral infections results in viral clear-
ance. Therefore, continuously replicating viral infections represent scenarios of an ineffective
immune response or immune tolerance. Mechanistic studies of persistently replicating viral
infections including lymphocytic choriomenengitis virus (LCMV) and murine hepatitis virus
(MHV) mouse models have provided numerous insights into immune mechanisms of viral
persistence [1–4]. In general, study of these and other models have focused on adaptive
immune tolerance or the loss of adaptive immune function in determining viral persistence [5–
8]. Thus, a paradigm has emerged that viral persistence is linked to defective or tolerant adap-
tive immune responses [3].
Noroviruses (NoVs) are a leading cause of epidemic viral gastroenteritis worldwide. Human
NoV and the closely related murine NoV (MNoV) also establish persistent asymptomatic
infection, which may contribute to spread and population-level persistence in between out-
breaks [9–12]. Study of MNoV strains that differ in persistence has begun to identify viral and
host correlates of persistent infection. MNoV strain CW3 is cleared whereas strain CR6 persists
in wild type mice [10,13]. We recently discovered that persistent intestinal CR6 infection is
cleared by IFN-λ-stimulated innate responses with no requirement for an adaptive immune
response [14,15]. IFN-λ is closely related to type I IFN, but with more specialized roles at epi-
thelial surfaces [16]. This finding suggests that the adaptive immune response is not always
necessary for control of persistent infection and that IFN responses play a role in MNoV
persistence.
Whereas IFN-λ clears intestinal CR6 persistence, the type I IFN response prevents systemic
spread of persistent infection [15]. CW3 spreads systemically and is controlled early by the
type I IFN response [13,17]. Therefore, in the present study, we sought to identify the role of
type I IFN in control of systemic CW3 persistence. We found that type I IFN receptor (IFNAR)
expression on dendritic cells (DCs) was necessary for CW3 clearance. The adaptive immune
response generated in mice with IFNAR deficient DCs was of increased magnitude, commen-
surate with the increased early viral replication, and the functional capacity of adaptive
immune cells was maintained during persistent infection. Therefore, CW3 persistence in this
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model represents an example of viral persistence due to innate rather than adaptive immune
deficiency.
Results
Type I IFN response in myeloid cells prevents viral persistence
Cytosolic RNA receptors and membrane toll-like receptors cooperate to sense viral infection
and lead to induction of type I and type III IFNs. We examined the ability of CW3 to persist
in mesenteric lymph nodes (MLN) of mice lacking the cytosolic RNA sensor MDA5 (Ifih1-/-)
or the downstream signal transducing molecule MAVS (Mavs-/-). We also examined mice
lacking signal transducers for toll like receptor (TLR) signaling Myd88 or Trif (Myd88-/- or
Ticam1-/-). None of these individual signaling molecules was critical for CW3 clearance (Fig
1A). However, mice lacking the transcription factors IRF3 and IRF7 (Irf3x7-/-), which are uti-
lized for interferon gene transcription by both cytosolic sensing and TLR pathways, failed to
clear CW3 (Fig 1A). Thus, global defects in induction of IFN lead to viral persistence.
Ifnar1-/- mice succumb to CW3 infection within seven days indicating that type I IFN
responses are critical for control of CW3 (Fig 1A)[17]. It was recently shown that mice with
selective deletion of Ifnar1 in macrophages (Ifnar1flox/flox x LysM-cre) or DCs (Ifnar1flox/flox x
CD11c-cre) also exhibit increased CW3 titers early after inoculation [17]. However, unlike
Ifnar1-/- mice, these lineage-specific Ifnar1 deficient mice survive CW3 infection. To assess
viral clearance in these mice, we sacrificed mice 21 days after inoculation and measured viral
genomes in the MLN. Persistent CW3 was detected in mice with either LysM-specific or
CD11c-specific Ifnar1 deficiency (Fig 1B). In contrast, cre-negative littermate control mice
or mice lacking IFNAR on Villin-expressing intestinal epithelial cells (Ifnar1flox/flox x Villin-
cre) were able to clear CW3 infection (Fig 1B). Together, these data indicate that reduced
induction of IFN or failure of myeloid cell subsets to respond to type I IFN results in CW3
persistence.
Type I IFN response in myeloid cells prevents systemic persistence
In immunocompetent mice, the persistence of MNoV strain CR6 is specifically localized to the
intestine and MLN whereas CW3 spreads systemically but does not persist [13,15]. Therefore,
we assessed the tropism of CW3 over time in mice with CD11c-specific deletion of Ifnar1
Fig 1. Type I IFN response in myeloid cells prevents viral persistence. Ifih1-/-,Mavs-/-,Myd88-/-,
Ticam1-/-, IRF3x7-/-, and Ifnar1-/-mice (A) or Cre-positive and Cre-negative littermates from Ifnar1flox/flox x
LysM-cre, Ifnar1flox/flox x CD11c-cre, and Ifnar1flox/flox x villin-cre crosses (B) were tested for the ability to clear
CW3 infection. Mice were inoculated with CW3, and viral genomes were quantified in the MLN on day 21.
Data is combined from at least two experiments with a total of 5–11 mice per group. Statistical significance
determined by Kruskal-Wallis test. n.s = p>0.05, * = p0.05, ** = p0.01, *** = p0.001, **** = p0.0001.
doi:10.1371/journal.ppat.1005684.g001
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(subsequently referred to as CD11c-Ifnar1-/-). Viral genome copies were dramatically increased
in CD11c-Ifnar1-/- mice four days after inoculation in systemic and intestinal tissues as well as
in the stool (Fig 2A). The greatest differences in genome copy number on day four were in the
spleen (15,000-fold), liver (4,000-fold) and MLN (2,000-fold). CW3 was cleared from all tissues
in control mice by 14 days after inoculation. The high titers of CW3 in CD11c-Ifnar1-/- mice
were partly controlled between day 4 and day 14, with reductions in viral genomes between
8–400 fold (Fig 2A). However, persistence of viral genomes was observed in the spleen, liver
and MLN of CD11c-Ifnar1-/- mice for at least 35 days (Fig 2A). CW3 was only sporadically
detected in the ileum and colon of CD11c-Ifnar1-/- mice after day 21 and was undetectable in
the stool of CD11c-Ifnar1-/- mice after day 14 (Fig 2A). Thus, CW3 persistence in CD11c-
Ifnar1-/- was primarily localized to systemic rather than intestinal tissues. Similarly, CW3
persisted in the spleen and MLN but not in the colon of Irf3x7-/- mice (Fig 2B). These data are
consistent with a primary role of the type I IFN response in DCs broadly limiting early viral
replication and preventing viral persistence in systemic tissues.
The early increase in viral genomes by>1000-fold in systemic tissues suggested that inter-
feron-stimulated genes (ISGs) and other genes related to IFN signaling or recruitment of
immune cells may not be appropriately regulated in CD11c-Ifnar-/-mice. Therefore, we quanti-
fied representative ISGs and chemokines in the spleen on day 3 after inoculation to determine
if there was a broad defect in induction of the anti-viral transcriptional response. The cell-
intrinsic antiviral mediators Ifit1 and Isg15 were present in significantly greater quantities in
CD11c-Ifnar1-/- mice (Fig 3). Additionally, transcripts for the T cell chemokine CXCL9 were
increased and transcripts for the macrophage chemokine CCL5 were unchanged in CD11c-
Ifnar1-/- mice (Fig 3). These data demonstrate that IFN-stimulated genes and chemokines are
similar or increased in CD11c-Ifnar1-/- mice.
DCs have increased activation markers in CD11c-Ifnar1-/- mice
CW3 persists in Rag1-/- mice [18], which indicates that the absence of an adaptive immune
response permits CW3 persistence. DC activation and antigen presentation is central to initia-
tion of the adaptive immune response, and CW3 replicates in myeloid cells, including DCs
[19]. Therefore, we tested whether the increased viral replication in CD11c-Ifnar1-/- mice cor-
related with changes in DC number or activation. Three days after inoculation, the number of
DCs in CD11c-Ifnar1-/- mice was unchanged relative to naïve mice or cre-negative littermate
controls (Fig 4A). Furthermore, DCs in CD11c-Ifnar1-/- mice exhibited increased cell surface
expression of MHCI (Kb), MHCII, and costimulatory molecules CD40, CD80, and CD86
compared to littermate controls (Fig 4B). These data demonstrate that type I IFN signaling on
DCs is not necessary for their maturation in this context. In fact, we observe increased activa-
tion of DCs in CD11c-Ifnar1-/- mice correlating with the increase in viral replication (Figs 1B
and 2A).
NK cells express low levels of CD11c and, therefore, may have altered expression of
IFNAR1 in CD11c-Ifnar1-/- mice. Indeed, when we stained NK cells from the spleen three days
after inoculation with CW3, expression of CD11c was similar and expression of IFNAR1 was
modestly reduced in CD11c-Ifnar1-/- mice. We further assessed NK cell numbers and expres-
sion of the surface markers KLRG1, CD62L, and Ly6C to determine if NK cell recruitment
or differentiation was altered by the reduced IFNAR1 expression. NK cell numbers were
unchanged (S1A Fig); NK cell expression of KLRG1 and Ly6C was not changed and expression
of CD62L was modestly increased in CD11c-Ifnar1-/- mice (S1B Fig). These data suggest that a
modest reduction in IFNAR1 expression on NK cells does not alter their recruitment or sub-
stantially change their activation following CW3 infection.
Interferon Response in CD11c Positive Cells Determines Persistent Infection
PLOS Pathogens | DOI:10.1371/journal.ppat.1005684 June 21, 2016 4 / 19
Fig 2. Type I IFN response in myeloid cells prevents systemic persistence. CD11c-Ifnar1-/- mice and
littermate controls (A) or IRF3x7-/-mice (B) were inoculated with CW3 and the indicated tissues were
collected on days four, eight, 14, 21, and 35 for viral genome quantification by qPCR. Tissues from IRF3x7-/-
mice (B) were collected on day 21 only. Data is combined from at least two experiments with a total of three to
eight mice per group. Statistical significance was determined by 2-way ANOVA (A) or Kruskal-Wallis test (B).
n.s = p>0.05, * = p0.05, ** = p0.01, *** = p0.001, **** = p0.0001.
doi:10.1371/journal.ppat.1005684.g002
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CW3 persistence in CD11c-Ifnar1-/- is associated with enhanced
humoral immunity
Antibody responses are important for keeping persistent viral infections in check [20], making
loss of humoral immunity in CD11c-Ifnar1-/- mice a potential basis for viral persistence. To
assess the humoral immune response to CW3 in CD11c-Ifnar1-/- mice, we measured the anti-
body response to viral particles or the NS1 protein by ELISA. Titers of serum antibodies to
both viral particles and the viral protein NS1 were significantly higher (3- and 70-fold respec-
tively) in CD11c-Ifnar1-/- mice compared to littermate controls (Fig 5A). To determine if the
increased antibody titers resulted in enhanced neutralization of viral particles, we performed a
serum neutralization assay. Serum from CD11c-Ifnar1-/- mice was more effective at neutraliza-
tion of PFUs than serum from littermate controls at the 10−2 dilution (Fig 5B). Together, these
data demonstrate that there is increased seroconversion and virus neutralization in CD11c-
Ifnar1-/- mice. Thus, persistence of CW3 in these mice is not correlated with defective humoral
immunity, and instead the humoral immune response in persistently infected CD11c-Ifnar1-/-
mice is enhanced.
CW3 persistence in CD11c-Ifnar1-/- mice is associated with enhanced
CD8 T cell expansion
Similar to NK cells, T cells can express low levels of CD11c when activated. Therefore, we stained
T cells for expression of IFNAR1 to determine if it was altered in CD11c-Ifnar1-/- mice. T cells
from CD11c-Ifnar1-/- mice had 25% less IFNAR1 in uninfected mice and 50% less IFNAR1
expression 8 days post-inoculation with CW3 (Fig 6A). Thus, expression of IFNAR1 is modestly
reduced on T cells in CD11c-Ifnar1-/- mice and may impact their activation in response to
virally-induced IFN. Prior work identified the immunodominant CD8 T cell epitope for CW3
[21], which we used to assess the cellular immune response in CD11c-Ifnar1-/- mice. At the
peak of T cell expansion eight days after inoculation, we observed an increased proportion of
CW3-specific CD8 T cells in spleens (1.4-fold), MLNs (3-fold), and Peyer’s patches (2-fold) of
CD11c-Ifnar1-/- mice compared to cre-negative littermate controls (Fig 6B). Likewise, a greater
proportion of CD8 T cells in spleens of CD11c-Ifnar1-/- mice responded by expressing IFNγ
(1.7-fold), TNFα (1.3-fold), or the degranulation marker CD107a (1.3-fold) following peptide
restimulation ex vivo (Fig 6C). Among cells that responded to peptide restimulation in vitro,
there was no significant difference in number of simultaneous functions (IFNγ production,
Fig 3. Increased type I IFN stimulated genes in in CD11c-Ifnar1-/- mice.CD11c-Ifnar1-/- mice and C57BL/
6 controls were inoculated with CW3 and spleens were collected on days three for quantification of the
indicated interferon stimulated genes by qPCR. Data is combined from two experiments. Statistical
significance was determined by unpaired t test. n.s = p>0.05, * = p0.05, ** = p0.01.
doi:10.1371/journal.ppat.1005684.g003
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Fig 4. DCs have increased activationmarkers in CD11c-Ifnar1-/- mice.DCs (CD3-negative,
CD19-negative, CD11c-positive, MHCII-positive) from CD11c-Ifnar1-/- mice and littermate controls (cre-
negative) 3 days after innoculation with CW3 were quantified (A) and stained for surface markers (B). The
geometric mean fluorescence intensity (Geo. MFI) is shown for MHCmolecules MHCI-Kb and MHCII-IA/IE,
and markers of activation: CD40, CD80, and CD86. Geometric MFIs were normalized in each experiment to
the average geometric MFI of each marker on DCs from naïve mice (uninfected cre-positive and cre-negative
Interferon Response in CD11c Positive Cells Determines Persistent Infection
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TNFα production, or degranulation) per cell (Fig 6E). To determine if there were increased T
cell cytokine responses in vivo we quantified transcripts for IFNγ, TNFα, and Granzyme B from
spleens of mice 8 days after inoculation with CW3. There were increased transcripts for IFNγ
and Granzyme B, while TNFα transcripts were unchanged (Fig 6D). Together, these data indi-
cate that, although there is a decrease in T cell IFNAR1 expression, persistence of CW3 in
CD11c-Ifnar-/-mice is not correlated with a defect in CD8 T cell expansion or functionality. In
fact, there was an increased expansion of equally functional CD8 T cells in CD11c-Ifnar1-/- mice.
CW3-specific CD8 T cells are functional during persistent infection
Early CD8 T cell expansion in persistent infection can be followed by clonal loss or clonal dys-
function [5]. Therefore, we assessed the CW3-specific CD8 T cell response at day 21 after inoc-
ulation to determine whether there was a loss of CD8 T cells or a decrease in CD8 T cell
functionality. At day 21 there was an increased proportion (8-fold) of CD8 T cells in spleens of
CD11c-Ifnar1-/- mice compared to control mice (Fig 7A). There were also an increased propor-
tion of CD8 T cells from spleens of CD11c-Ifnar1-/- mice expressing IFNγ (2.7-fold), TNFα
(7.5-fold), or CD107a (4.1-fold) following peptide restimulation ex vivo (Fig 7B). Furthermore,
there was no difference in the number of simultaneous functions per cell following peptide
restimulation (Fig 7D). We also analyzed cell surface expression of the following proteins: 1.
littermates). Representative histograms are shown. Data is combined from two experiments and individual
mice are represented by each data point. Statistical significance was determined by 1-way ANOVA.
n.s = p>0.05, * = p0.05, *** = p0.001, **** = p0.0001.
doi:10.1371/journal.ppat.1005684.g004
Fig 5. CW3 persistence in CD11c-Ifnar1-/- mice is associated with enhanced humoral immunity. Serum
was collected from CD11c-Ifnar1-/- mice and littermate controls 14, 21, and 35 days after infection with CW3.
Binding of serum IgG to plate-bound virons or NS1 protein was determined by ELISA (A). Dilutions of day 35
serum were incubated with CW3 and the neutralization of viral infection was determined by plaque assay (B).
Data is combined from two experiments with a total of five to eight mice per data point. Statistical significance
was determined by 2-way ANOVA. n.s = p>0.05, * = p0.05, ** = p0.01, *** = p0.001.
doi:10.1371/journal.ppat.1005684.g005
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PD-1, which is upregulated transiently after activation and sustained on exhausted T cells; 2.
Ly6C, which is upregulated and sustained after activation but downregulated on exhausted T
cells; 3. CD103, which is transiently downregulated after activation [21,22]. There was no dif-
ference in expression of these cell surface proteins on CW3-specific CD8 T cells from CD11c-
Ifnar1-/- mice in comparison to cre-negative littermate controls (Fig 7E). Finally, we quantified
in vivo transcripts for IFNγ, TNFα, and Granzyme B and observed increased transcripts for
TNFα and Granzyme B with no significant difference in IFNγ transcripts (Fig 7C). Together,
these data indicate that virus-specific CD8 T cells in CD11c-Ifnar1-/- mice are maintained at
higher frequencies and remain functional during persistent CW3 infection.
The adaptive immune response generated in persistently infected
CD11c-Ifnar1-/- is functional in an Ifnar1-sufficient environment
The enhanced adaptive immune response in CD11c-Ifnar1-/- mice (Figs 5–7) correlated
with increased early viral replication and reduced viral titers over time, but did not result in
Fig 6. CW3 persistence in CD11c-Ifnar1-/- mice is associated with enhanced CD8 T cell expansion.
Cells were collected from spleens, MLNs, or Peyer’s patches of CD11c-Ifnar1-/- mice and controls eight days
after infection with CW3. (A) Total CD8 T cells were analyzed for expression of IFNAR1. (B) The number or
percentage of CW3-tetramer positive CD8 T cells was determined by flow cytometry from the indicated
tissue. (C) Splenocytes were stimulated ex vivowith CW3 peptide and stained for cell surface CD107a and
intracellular IFNγ and TNFα. (D) RNA extracted from spleens was used to quantitate transcripts for Ifng, Tnfa,
andGzmb. (E) The percentage of cells in (C) positive for one, two, or three of the markers of activation is
shown. Data in (B) is combined from three experiments and data in (A), (C), (D) and (E) is combined from two
experiments with seven mice per data point in (E). Statistical significance was determined by unpaired t test
(B, C and D) or 2-way ANOVA (A and C). n.s = p>0.05, * = p0.05, ** = p0.01, *** = p0.001,
**** = p0.0001.
doi:10.1371/journal.ppat.1005684.g006
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elimination of the virus from systemic tissues (Fig 2A). Although DCs are activated (Fig 4)
and a CD8 T cell response is initiated (Fig 6), we considered the possibility that virally-
infected Ifnar1-deficient DCs were unable to present viral antigens to activated T cells. To
test this possibility, we utilized a CW3 strain that was engineered to express the peptide SIIN-
FEKL from chicken ovalbumin (CW3-SIINFEKL) and an antibody that recognizes SIIN-
FEKL in the groove of the class I MHC molecule H2-Kb. DCs, Macrophages, and B cells can
be infected by CW3 [19,23] whereas T cells have not been shown to support CW3 infection.
Staining of CD11c-Ifnar1-/- splenocytes three days after inoculation showed a modest
increase in staining intensity for SIINFEKL-Kb on B cells, macrophages, and DCs but not T
cells following inoculation with CW3-SIINFEKL compared to the corresponding cells from
mice inoculated with CW3 (Fig 8A). Therefore, the absence of Ifnar1 does not prevent
Fig 7. CW3-specific CD8 T cells are functional during persistent infection. Cells were collected from
spleens of CD11c-Ifnar1-/- mice and littermate controls 21 days after infection with CW3. The number and
percentage of CD8 T cells that were tetramer positive (A) or responded to ex vivo peptide stimulation (B)
were determined as in Fig 4. (C) RNA extracted from spleens was used to quantitate transcripts for Ifng, Tnfa,
andGzmb. (D) The percentage of cells in (B) positive for one, two, or three of the markers of activation is
shown. (E) Tetramer positive CD8 T cells in the spleens of CD11c-Ifnar1-/- (red lines) and littermate controls
(blue lines) were analyzed for cell surface expression of Ly6C, CD103, and PD-1. Grey lines are histograms
of total CD8+ T cells. Dot plots show the geometric MFI for each marker. Data in (E) is representative of two
independent experiments. Data in (A-D) is combined from two (C) or three (A, B, D) experiments with
individual mice shown in (A-C) and 13 mice per data point in (D). Statistical significance was determined by
unpaired t test (A, B, C) or 2-way ANOVA (D). n.s = p>0.05, * = p0.05, ** = p0.01, *** = p0.001,
**** = p0.0001.
doi:10.1371/journal.ppat.1005684.g007
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Fig 8. The adaptive immune response generated in persistently infected CD11c-Ifnar1-/- mice is
functional in an Ifnar1-sufficient environment. (A) CD11c-Ifnar1-/- mice were infected with CW3 (filled gray
histograms) or CW3 engineered to express the SIINFELK peptide (Red-lined histograms). Three days after
inoculation, splenocytes were isolated and stained with an antibody that recognizes H2-Kb with SIINFEKL
bound in the peptide-binding groove. Overlain histograms from individual mice show fluorescence intensity of
staining on T cells (CD3+, CD19-), B cells (CD19+, CD3-), Macrophages (CD3-, CD19-, F4/80+, CD11blow),
or DCs (CD3-, CD19-, CD11c+, MHCII+) as indicated. (B) A portion of the MNoV VP1 gene was amplified by
PCR from spleen tissue 21 days after inoculation and sequenced by Sanger sequencing. The shown
chromatogram includes the region encoding the immunodominant CD8 T cell epitope and is representative of
sequencing results from four mice. (C and D) Splenocytes were collected from CD11c-Ifnar1-/- and littermate
controls 21 days after infection with CW3. 107 splenocytes were injected I.P. into Rag-/-mice that had been
infected with CW3 21 days prior. Spleens and Ileums were collected from Rag-/- seven days after splenocyte
transfer. Viral titers in tissues were determined by qPCR for viral genomes (C) and plaque assay (D). Data in
C and D is combined from two experiments with individual mice shown. Statistical significance was
determined by one-way ANOVA (A) or Kruskal-Wallis test (B) or. n.s = p>0.05, * = p0.05, ** = p0.01,
*** = p0.001, **** = p0.0001.
doi:10.1371/journal.ppat.1005684.g008
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display of antigen on cells susceptible to viral infection. However, it remained possible that
CW3 developed mutations to evade recognition by CD8 T cells. To determine if mutation of
the CD8 T cell epitope occurred during persistent CW3 infection, sequencing of virus from
the spleen was performed 21 days after inoculation. Examination of the sequence of persis-
tent CW3 revealed no deviation in the CD8 T cell epitope sequence from the virus in the
inoculum (Fig 8B). Therefore, the CD8 T cell response fails to clear CW3 despite persistence
of the un-mutated epitope sequence.
The preceding data suggested that despite presentation of antigen and generation of cellular
immunity, a functional adaptive immune response could significantly diminish viral infection
but could not fully clear it from Ifnar1-deficient innate immune cells. To test the function of
the adaptive immune system in a setting where all virally infected cells are Ifnar1-sufficient, we
utilized a previously published Rag1-/- splenocyte transfer in which CD4 T cells and CD8 T
cells contribute to clearance of viral infection [24]. CD11c-Ifnar1-/- or littermate control mice
were infected with CW3; 21 days later, splenocytes were isolated and transferred into persis-
tently infected Rag1-/- mice. Six days after splenocyte transfer, genomes were detected by qPCR
in spleens and ileums from Rag1-/- and viral titers were determined mice by plaque assay. Sple-
nocytes from either CD11c-Ifnar1-/- or littermate control donors were similarly able to clear
PFUs from the spleen and ileum (Fig 6A). Likewise, splenocytes from either donor were simi-
larly able to reduce viral genomes in spleen (10-fold) and ileum (10-fold) (Fig 6B). These data
demonstrate that the adaptive immune response in CD11c-Ifnar1-/- mice, including both CD4
and CD8 T cells, is functional in an Ifnar1-sufficient environment in vivo and suggest that
increased viral replication in Ifnar1-deficient cells is sufficient for establishing persistent viral
replication despite a functional adaptive immune response.
Dendritic cell-intrinsic IFNAR response is required for clearance of CW3
infection
The data thus far strongly suggested that DC stimulation of adaptive immunity is not pre-
vented by IFNAR deficiency. We next sought to determine whether the presence of a subpopu-
lation of IFNAR-deficient cells was sufficient for increased CW3 replication. To this end, we
generated mixed bone marrow chimeras by reconstitution of irradiated CD45.1 congenic recip-
ients with a 50% mixture of CD11c-Ifnar1-/- bone marrow (CD45.2) and congenic wild-type
bone marrow (CD45.1). As a control, a separate cohort of irradiated CD45.1 recipients was
reconstituted with a 50% mixture of wild-type bone marrow (CD45.2) and congenic wild-type
bone marrow (CD45.1). Six weeks after reconstitution there was an equivalent proportion of
CD45.1 and CD45.2 expression on cells in the blood from each group, indicating an equal
engraftment of cells from each donor (Fig 9A).
Six weeks after reconstitution, mixed bone marrow chimeras were inoculated with CW3.
Three days after inoculation, the amount of viral genomes in the blood was determined as a
measure of early systemic viral replication. 50% CD11c-Ifnar1-/- bone marrow chimeras were
unable to control early systemic viral replication with 3,000-fold more viral genomes per
microliter of blood compared to control chimeras (Fig 9B). Furthermore, early shedding of
viral genomes in the feces of 50% CD11c-Ifnar1-/- bone marrow chimeras on days five and
seven was increased 37-fold and 10-fold respectively compared to control chimeras (S2A Fig).
This demonstrates that the presence of a subpopulation of IFNAR-deficient DCs is sufficient
for increased early viral replication. Correspondingly, the presence of mixed wild-type leuko-
cytes is not sufficient to enable early viral control.
Unexpectedly, mixed bone marrow chimeras had increased susceptibility to infection; three
out of eight 50% CD11c-Ifnar1-/- chimeras died prior to day eight. Additionally, one control
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mouse died on day 20 (Fig 9C). On day 21, we observed reduced numbers of lymphocytes in
spleens of surviving 50% CD11c-Ifnar1-/- compared to control chimeras (S2B Fig). The
increased lethality and reduced number of leukocytes suggested that the process of bone mar-
row transplantation results in an immunocompromised state and increased susceptibility to
CW3. However, the number and chimerism of DCs in 50% CD11c-Ifnar1-/- bone marrow chi-
meras was not significantly different from that control chimeras (S2C and S2D Fig) allowing us
to compare viral titers in surviving mice from these two groups. Viral genomes were signifi-
cantly higher in the spleen (1,000-fold), liver (200-fold), MLN (1,400-fold), and colon
(>300-fold) of 50% CD11c-Ifnar1-/- bone marrow chimeras compared to control chimeras
(Fig 9D). These data indicate that the presence of mixed wild-type DCs does not rescue control
of persistent viral replication. Taken together with the preceding data, this suggests that the
presence of a subpopulation of cells with increased susceptibility to CW3 infection is sufficient
for increased early and persistent viral replication.
Discussion
We have shown here that selective deficiency in the type I IFN response in DCs results in
MNoV persistence. Prior studies utilizing the LCMVmodel causally link diminished CD8 T
Fig 9. Dendritic cell-intrinsic IFNAR response is required for clearance of CW3 infection.Mixed bone
marrow chimeras were generated by reconstitution of irradiated CD45.1 recipients with 50%wild-type
CD45.2 bone marrow and 50%wild-type CD45.1 bone marrow (labeled control) or 50% CD11c-Ifnar1-/-
(CD45.2) bone marrow and 50%wild-type CD45.1 bone marrow (labeled 50%CD11c-Ifnar1-/-). (A) Prior to
infection, 50% chimerism was confirmed by staining of blood cells with antibodies to CD45.1 and CD45.2. (B)
Three days after infection with CW3, viral genomes were quantitated per microliter of blood. (C) Survival
curve of mixed bone marrow chimeras. (D) 21 days after infection with CW3, viral genomes were quantitated
in spleen, liver, MLN, and colon. Data is combined from two experiments with individual mice shown.
Statistical significance was determined by t-test. n.s = p>0.05, **** = p0.0001.
doi:10.1371/journal.ppat.1005684.g009
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cell functionality to viral persistence [6] and other studies have demonstrate a role for type I
IFN in regulating this process [25–29]. Furthermore, antigen abundance has been positively
correlated with the degree of CD8 T cell dysfunction [5,30]. The MNoV persistence demon-
strated herein contrasts with this paradigm as it was not associated with failure to generate an
adaptive immune response or loss of adaptive immune function. In fact, there is an enhanced
adaptive immune response commensurate with increased viral replication, and this enhanced
adaptive immune response is sustained during persistent infection. These data demonstrate
that an innate immune defect in type I IFN can result in viral persistence without attendant
effects on the adaptive arm of the immune system. These results provide a different view of
viral persistence than prior work in the LCMVmodel. However, it is important to note that
antigen abundance may be lower in the MNoV model relative to the LCMVmodel. Addition-
ally, the importance of type I IFN in protecting against lethal infection differs between CW3
and LCMV [17,25], providing a potential basis for differing roles of type I IFN in these two
models.
In the MNoV model of persistence studied here, we observed that increased viral replication
due to defects in the type I IFN pathway is linked to viral persistence: Ifnar-/- mice have high
early viral replication and succumb to infection; Irf3x7-/- mice have marginally lower peak viral
replication [17] and allow CW3 to persist; lineage specific deletion of Ifnar1 in CD11c or LysM
expressing cells also results in less viral replication than Ifnar-/- [17] but allows MNoV persis-
tence; Ifih1-/- mice have small increases in viral replication [31] but are able to clear the infec-
tion; lineage specific deletion of Ifnar1 in Villin-expressing cells leads to no change in viral titer
and clearance. The relatively greater effect of IFNAR in myeloid cells rather than intestinal epi-
thelial cells is likely due to the preferential replication of CW3 in myeloid cells and/or low
IFNAR expression on intestinal epithelial cells [32]. Together, these findings support a model
where varying levels of type I IFN signaling inversely correlate with peak viral replication and
viral clearance.
An additional conclusion from these data is that viral titer is not always positively correlated
with adaptive immune dysfunction. In the LCMVmodel, increased viral titer and associated
antigen levels are predictive of T cell clonal deletion or loss of T cell function [5]. Unlike the
LCMVmodel, persistent infection of CW3 in CD11c-Ifnar1-/- mice is not correlated with loss
of CD8 T cell numbers or function. Instead, increased viral titers are balanced by a commensu-
rate increase in CD8 T cell expansion and antibody production: wild type mice have intact
innate control and a relatively lower level of CD8 T cell expansion and antibody production;
Ifnar1-/- mice represent an unbalanced scenario with uncontrolled early viral replication result-
ing in death prior to development of an adaptive response; CD11c-Ifnar1-/- mice represent a
‘sweet spot’ where increased viral growth is controlled but not cleared by an enhanced adaptive
immune response resulting a persistent balance between viral replication and clearance (Fig
10). This model is simplistic and does not consider other components of the innate immune
response, but represents a rationale for viral persistence in the presence of an enhanced adap-
tive immune response.
The implication of this model is that the primary mechanistic basis for certain persistent
infections could be manipulation of IFN, or other innate antiviral responses. Likewise, these
data imply that some persistent infections could be treated by modulating innate immunity,
particularly type I IFN, rather than targeting adaptive immune responses. Indeed, both of these
principles are manifest in persistent HCV infection in humans. The HCV NS3/4A protease
inhibits the induction of IFN by cleaving MAVS [33]. Prior to the recent development of small
molecule inhibitors of HCV replication, the most effective therapy for persistent HCV infec-
tion included IFN treatment. So, successful treatment for HCV serves to circumvent the viral
inhibition of IFN induction. Thus, HCV may be an example of a medically relevant persistent
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viral infection that persists due, in part, to loss of innate immune function. Persistence of other
continuously replicating RNA viruses, such as chikungunya, measles, polyomavirus, may be
similarly due to ineffective innate responses.
Materials and Methods
Mice and infections
Ifnar1-/- (Ifnar1tm1Agt), Ifnar1flox/flox (Ifnar1tm1Uka), LysM-cre (Lyz2tm1(cre)Ifo), CD11c-cre
(Tg(Itgax-cre,-EGFP)), villin-cre (Tg(Vil1-cre)Gum), IRF3-/- (Irf3tm1Ttg), IRF7-/- (Irf7tm1Ttg),
Ifih1-/-,Mavs-/-, Ticam1-/-, andMyd88-/- mice were maintained at Washington University as
described [34]. All mice were bred on C57BL/6 background. Cre-negative littermates from
Ifnar1flox/flox x villin-cre, Ifnar1flox/flox x LysM-cre, and Ifnar1flox/flox x CD11c-cre crosses were
used as controls. In few experiments as indicated, C57BL/6 mice were used as controls. Mice
were infected at 7–12 weeks of age. MNoV strain CW3 stocks were generated as described [13]
and diluted in media to a concentration of 4x107 PFU per mL. 106 PFU (25 μL) was adminis-
tered orally by pipet to each mouse. CW3-SIINFEKL was generated by inserting the epitope
encoding sequence into the ORF1 polyprotein between NS4 and NS5 as previously described
[35].
CD45.1 congenic mice used as bone marrow recipients were obtained from Jackson Labora-
tories (Bar Harbor, ME) and housed at Oregon Health & Science University. Bone marrow was
isolated from CD45.1 congenic mice and CD45.2 experimental mice and mixed at a 1:1 ratio.
Recipient CD45.1 mice were irradiated with 1200rad and 2.5x106 total donor bone marrow
cells were injected intravenously. Mice were given ciprofloxacin in the drinking water for two
weeks and used for experiments after six weeks.
Ethics statement
Protocols for animal care and use were approved by the Animal Studies Committee at Wash-
ington University in St. Louis (protocol #20140244) and Oregon Health & Science University
(protocol # IP00000228) according to standards set forth in the Animal Welfare Act.
Fig 10. Model for the relationship between IFNAR signaling, viral replication, the adaptive immune
response, and persistence. The contribution of the adaptive immune response depends on the level of type
I IFN deficiency. When the type I IFN response is intact, innate immunity is relatively effective at control of
MNoV and a small magnitude of adaptive immune response is sufficient to clear the infection. When a
susceptible cell type (i.e. DCs) lacks the ability to respond to type I IFN, MNoV replication is increased, a
larger magnitude of adaptive immune response is elicited, and infection is controlled but not cleared. When
type I IFN signaling is completely absent, MNoV replication is at a maximum and the host succumbs to
infection prior to generation of a protective adaptive immune response.
doi:10.1371/journal.ppat.1005684.g010
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Quantitative RT-PCR
Tissues were dissected and flash frozen. RNA from tissues was isolated using Trizol (Life Tech-
nologies) and DNA was removed using the DNAfree kit (Life Technologies). RNA from stool
was isolated using ZR Viral RNA kit (Zymoresearch). RNA was reverse transcribed using
ImPromII reverse transcriptase system (Promega). MNoV genome quantities and transcripts
for the housekeeping gene, ribosomal protein S29 (RPS29) were detected using the following
primers and probes: MNoV Forward primer, CACGCCACCGATCTGTTCTG; MNoVMGB
Probe, CGCTTTGGAACAATG; MNoV Reverse primer, GCGCTGCGCCATCACTC; RPS29
Forward primer, GCAAATACGGGCTGAACATG; RPS29 Probe, CCTTCGCGTACTGCCG
GAAGC; RPS29 Reverse primer, GTCCAACTTAATGAAGCCTATGTC. Transcripts for Ifit1
(Mm.PT.58.32674307), Isg15(Mm.PT.58.41476392.g), Cxcl9(Mm.PT.58.13098261), Ccl5(Mm.
PT.58.43548565), Ifng(Mm.PT.58.30096391), Tnfa(Mm.PT.58.12575861), Gzmb (Mm.
PT.58.12967220) were detected using PrimeTime qPCR assays from integrated DNA technolo-
gies (IDT). Copy number was determined using a standard curve generated by dilution of a
plasmid encoding the target sequence of interest.
ELISA
Immulon 2HB plates (Thermo Fisher) were coated with UV inactivated MNoV virions or bac-
terially-produced MNoV NS1 (amino acids 28–114) in PBS. Plates were washed three times in
ELISA wash buffer (0.15M NaCl, 0.05% Tween 20) and blocked with 3% bovine serum albu-
min. Serum was diluted in ELISA III buffer (0.15M NaCl, 0.001M EDTA, 0.05M Tris, 0.05%
Tween 20, 0.1% BSA, pH 7.4) and added to plate for 1 hour at 37°C. Unbound serum antibody
was removed by washing four times in ELISA wash buffer. Goat-anti-mouse-HRP (Jackson
Immunoresearch) was diluted 1:1000 in ELISA III buffer and added to plate for 1 hour at 37°C.
Plate was washed four times in ELISA wash buffer. HRP activity was detected by adding ELISA
substrate buffer (0.1M sodium citrate, 1mM ABTS, 0.016% hydrogen peroxide) and stopping
in 0.2N Phosphoric Acid. Absorbance was measured at 415nm.
Serum neutralization assay
Serum from mice infected for 35 days with MNoV was heat inactivated at 55°C for 30 minutes
and diluted 10-fold in cell culture media (DMEM supplemented with 10% fetal calf serum,
L-Glutamine, HEPES, and Pennecilin/Streptamycin). 10 PFU of MNoV strain CW3 was added
to each serum dilution in a total volume of 100 μL and incubated at room temperature for 30
minutes prior to inoculation of RAW cell monolayers in six-well plates. Inoculation of RAW
cells and plaque assay were performed as described [13].
Cell isolation and flow cytometry
Spleens, mesenteric lymph nodes, and Peyer’s patches were removed and forced through 70 μM
cell strainers to create single cell suspensions. Red blood cells in splenocyte suspensions were
lysed with ammonium chloride potassium (ACK) lysing buffer (Sigma). Dead cells were stained
with live/dead Aqua (Life Technologies). Surface antigens were stained with the following anti-
bodies: CD11c (eBioscience, clone N418), MHCII (BioLegend, clone M5/114.15.2), CD3ε (Bio-
Legend, clone 145-2C11), CD19 (BD biosciences, clone 1D3), CD8α (BD biosciences, clone 53–
6.7), CD4 (BioLegend, clone RM4-5), CD40, CD80, CD86, MHCI-Kb (BD biosciences, clone
AF6-88.5), CD44 (BD biosciences, clone IM7), PD-1 (BioLegend, clone RMP1-14), CD103
(BioLegend, clone 2E7), Ly6C (BioLegend, clone HK1.4), NKp46 (BioLegend, clone 29A1.4),
IFNAR1 (BioLegend, clone MAR1-5A3), KLRG1 (Tonbo, clone 2F1), CD62L (BioLegend, clone
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MEF-14), SIINFEKL peptide in grove antibody (BioLegend, clone 25-D1.16), CD45.1 (BioLe-
gend clone A20), CD45.2 (BioLegend clone 104). MHCI Kb tetramers with the CW3 immuno-
dominant epitope SWVPRLYQL were generated as described [21].
Peptide restimulation and intracellular cytokine staining
5x106 splenocytes were incubated in 96-well round bottom plates in triplicate with Monensin
(BioLegend), Brefeldin-A (BioLegend), CW3 peptide SWVPRLYQL (0.4 μg/mL), and the
CD107a antibody (eBioscience, clone ABL-93) for four to five hours at 37°C. Cells were sur-
face stained followed by fixation and permeabilization using the cytofix/cytoperm kit (BD
biosciences). Permeabilized cells were stained with antibodies for TNFα (BioLegend, clone
MP6-XT22), IFNγ (BD biosciences, clone XMG1.2) and analyzed by flow cytometry.
Splenocyte adoptive transfer assay
Adoptive transfer of splenocytes into persistently infected Rag1-/- mice was performed as
described [24]. Briefly, splenocytes were isolated from donors that had been infected with
CW3 and red blood cells were lysed. 107 splenocytes were injected i.p. into Rag1-/- recipients
that had been infected with CW3 for 21 days. Six days after transfer, tissues were harvested.
PFU were determined by plaque assay and genomes were quantified by qPCR.
Supporting Information
S1 Fig. NK cells have reduced IFNAR1 expression in CD11c-Ifnar1-/- mice and similar
expression of other phenotypic markers.NK cells (CD3-negative, CD19-negative, NKp46-
positive) from CD11c-Ifnar1-/- mice and C57BL/6 controls 3 days after innoculation with
CW3 were quantified (A) and stained for surface markers (B). The geometric mean fluores-
cence intensity (Geo. MFI) is shown for CD11c, IFNAR1, and markers of activation: KLRG1,
CD62L, and Ly6C. Data is combined from two experiments. Statistical significance was deter-
mined by unpaired t test. n.s = p>0.05,  = p0.05,  = p0.0001.
(TIF)
S2 Fig. CD11c-Ifnar1-/- mixed bone marrow chimeras have similar DC numbers and chime-
rism 21 days after CW3 infection. (A) Feces were collected from the mixed bone marrow chi-
meras in Fig 9 on the indicated days and viral genomes were quantified. (B-D) 21 days after
inoculation with CW3, splenocytes were isolated from mixed bone marrow chimeras in Fig 9.
(B) Numbers of total splenocytes, CD3+ T cells, CD19+ B cells, and CD11c+ MHCII+ DCs per
spleen. (C) Percentage of each indicated cell subset. (D) Ratio of CD45.1 (wild-type donor and
recipient) to CD45.2 (CD11c-Ifnar1-/- donor or wild-type control donor) cells of the indicated
cell subset. Data is combined from two experiments. Statistical significance was determined by
two-way ANOVA (A) or t-test (B-D). n.s = p>0.05,  = p0.05,  = p0.01,  = p0.001,
 = p0.0001.
(TIF)
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